Hevylite®

Hevylite provides prognostic information to identify patients at higher risk of a poor outcome. These patients may benefit from more frequent monitoring. Test results can predict outcomes, both from baseline tests at diagnosis and during monitoring.

• Predict outcome at maximum response to treatment - Identifying patients with optimal response and long survival is important for clinical guidance.

• MGUS (Monoclonal Gammopathy of Undetermined Significance) – Like Freelite, Hevylite can identify patients at risk of progression to active disease such as Multiple Myeloma
• An abnormal Hevylite ratio at diagnosis is an independent prognostic factor in patients with Multiple Myeloma